Reovirus infection represents an important viral disease affecting reptiles, particularly snakes, with the potential to cause significant morbidity and mortality in captive collections. Reoviruses are double-stranded RNA viruses belonging to the family Reoviridae, a large and diverse group that includes pathogens of numerous animal species. In reptiles, reoviruses have been associated with respiratory disease, gastrointestinal illness, neurological abnormalities, and systemic infections affecting multiple organ systems. The recognition of reoviruses as significant reptile pathogens has grown substantially in recent decades as molecular diagnostic tools have improved detection capabilities.
Reovirus infections have been documented in a wide range of reptile species, though snakes appear to be most commonly affected based on reported cases. Pythons and boas have been particularly well-documented hosts, with reoviruses identified as the cause of outbreaks in breeding collections and individual pet animals. Various other snake species have also been affected. Beyond snakes, reoviruses have been identified in lizards and chelonians, suggesting that the host range of these viruses extends across reptile orders. The true prevalence of reovirus infection in captive and wild reptile populations is likely underestimated due to the need for specific testing to confirm diagnosis.
The clinical impact of reovirus infection varies considerably depending on the viral strain, host species, and individual factors affecting immune competence. Some infections may be subclinical, with animals carrying and potentially shedding virus without showing obvious disease. Other infections cause progressive respiratory disease, potentially leading to pneumonia and respiratory failure. Neurological disease may develop in some cases, producing symptoms ranging from mild incoordination to severe paralysis. Gastrointestinal involvement can cause regurgitation, diarrhea, and failure to thrive. The temperature-dependent nature of reptile immunity means that husbandry conditions significantly influence disease outcomes.
No specific antiviral treatment exists for reovirus infection in reptiles, and management relies on supportive care while the immune system attempts to control the infection. Outcomes are variable, with some animals recovering while others succumb to progressive disease. Prevention through quarantine protocols, biosecurity measures, and optimal husbandry represents the most effective approach to managing reovirus risk in collections. Any reptile suspected of having reovirus infection should be evaluated by a reptile-experienced veterinarian to confirm the diagnosis and develop an appropriate management plan.
